Dongsung biopharmaceutical with 60 years of history provides customer-oriented total services and future-oriented marketing which covers cosmetics and finished medicine.
Dongsung Pharma's 'Vigasol' anti-dandruff treatment popular
Dongsung Pharma's anti-dandruff treatment 'Vigasol' is experiencing a shortage due to high demand. The product saw 28% growth in 2024 compared to 2023.
Multiple Korean companies reported Q2 2025 financial results, including Kiwoom Securities, SOOP, GS E&C, and others. Several firms announced investments, contracts, and corporate actions.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 10 of 10
Get full access to view complete information
Frequently Asked Questions Regarding Dongsung Bio Pharmaceutical Co., Ltd.
Company Overview
1957
Founded
Pharmaceutical Manufacturing
Industry
South Korea
Location
50,447,386
Ranking
10 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding Dongsung Bio Pharmaceutical Co., Ltd.
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.